Enter multiple symbols separated by commas

Pfizer Prevails in Patent Suit Against Teva

Pfizer said on Tuesday that a U.S. federal court upheld the three main patents covering its Celebrex painkiller, winning a challenge by generic drugmaker Teva Pharmaceutical Industries.

The decision bars Teva from launching a competitor drug in the U.S. until December 2015, Pfizer said.

Contact U.S. News


    Get the best of CNBC in your inbox

    Please choose a subscription

    Please enter a valid email address
    To learn more about how we use your information,
    please read our Privacy Policy.

Don't Miss

U.S. Video